FAP and neoplasm: However, efforts have been made to increase CAR-T efficacy and safety by directing delivery locally to the surgical site and by targeting proteins overexpressed in HNSCC tumor tissue compared to local adjacent tissue, namely FAP, HER3, and NKGD2.